Table 1.
In- and exclusion criteria.
Fig 1.
Consort diagram.
Table 2.
Trial schedule.
Table 3.
a) General patient information, b) Distribution of glaucoma diagnosis in population, c) Previous use of IOP-lowering eye treatments.
Fig 2.
IOP (in mmHg) of the studied eye across visits–PP population (n = 62).
Table 4.
Differences in IOP increase and decrease between the treatment groups.
Table 5.
Postoperative complications and treatments.
Table 6.
Grading of conjunctiva—ITT population (N = 62).
Fig 3.
Change of NEI VFQ 25 at visit 5 from baseline (visit 2)–ITT population (n = 62).
Table 7.
Adverse events—safety population (N = 59).